A 21-year-old Chinese woman presented with a 1-week history of high fever, myalgia, and a 2-month history of firm lumps. Examination found 2 large nontender erythematous indurated subcutaneous plaques with central atrophy on the left arm (Fig 1) and right buttock.
cultures, HIV results, and viral hepatitis serology results were negative. A biopsy specimen was taken from her arm plaque (Figs 2 and 3). A. Lupus profundus e Incorrect. Lupus profundus is more common in women and presents as subcutaneous nodules on arms, shoulders, buttocks, and face. It occurs in 2% to 5% of systemic lupus erythematosus (SLE) patients. Conversely, 10% to 15% of patients with lupus panniculitis have SLE. Histopathology findings show lobular lymphocytic panniculitis with epidermal and dermal changes of lupus, such as thickened basement membrane, interface changes, and superficial and deep, perivascular, periadnexal, lymphocytic inflammation with increased dermal mucin. In less than half of the cases, biopsy findings show lobular lymphocytic panniculitis without epidermal and dermal lupus changes. A. Miliary tuberculosis e Incorrect. Erythema induratum may be an immunologic hypersensitivity reaction to antigenic components of Mycobacterium tuberculosis and has been associated with miliary tuberculosis. 3 However, miliary tuberculosis is unrelated to SPTCL.
B. Sarcoidosis e Incorrect. Sarcoidosis may be associated with erythema nodusum.
C. Systemic PAN e Incorrect. Fever, myalgia, fatigue, peripheral neuropathy, and bowel and renal ischemia are manifestations, but the histopathology is not consistent with that of PAN.
D.
Acute SLE e Incorrect. There is significant overlap of clinical and histologic features in SPTCL and SLE with both conditions often presenting with a constellation of fever, constitutional symptoms, hepatitis, cytopenia, similar cutaneous manifestations, and associated autoimmune disorders. However, the skin biopsy result is not consistent with that of lupus panniculitis.
E. Hemophagocytic syndrome e Correct. Approximately 15% of SPTCL cases have underlying systemic involvement or hemophagocytic syndrome (HPS). These patients have a reduced 5-year overall survival rate of 46% compared with 80% in patients without HPS. HPS is diagnosed by at least 5 features including fever greater than 38.58C; splenomegaly; blood cytopenia; hypertriglyceridemia or hypofibrinogenemia; hemophagocytosis in the bone marrow, spleen, lymph nodes, or liver; low natural killer cell activity; elevated ferritin; and elevated soluble CD25 (soluble interleukin-2 receptor a). Bone marrow aspiration is important to detect marrow involvement. 4 Our patient had a constellation of fever, splenomegaly, cytopenia, hypertriglyceridemia, high ferritin, and bone marrow involvement, thereby confirming the presence of HPS. For systemic involvement, positron emission tomography-fludeoxyglucose body scan and computerized tomographic scans of the thorax, abdomen and pelvis are useful to characterize the location, size and depth of extracutaneous lesions. 1 T cells was observed in our case (Fig 3, B) and has been reported in SPTCL. The Ki-67 hotspots are not present in lupus panniculitis, which can help distinguish it from SPTCL. C. CD30 e Incorrect. CD30 is negative in SPTCL. However, it may be positive in primary cutaneous gd T-cell lymphoma.
D. CD45 e Incorrect. CD45 is negative in SPTCL.
E. CD56 e Incorrect. CD56 positivity is seen in primary cutaneous gd T-cell lymphoma but not SPTCL.
Abbreviations used:
HPS: hemophagocytic syndrome PAN: polyarteritis nodosa SLE: systemic lupus erythematosus SPTCL: subcutaneous panniculitislike T-cell lymphoma
